Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressDividends payablesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (HLTC) Non-Current Deffered Revenue (2020 - 2025)

National Healthcare Properties has reported Non-Current Deffered Revenue over the past 6 years, most recently at $9.2 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue rose 28.13% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $9.2 million, up 28.13%, while the annual FY2025 figure was $9.2 million, 28.13% up from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $9.2 million at National Healthcare Properties, down from $10.2 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $10.2 million in Q3 2025 and troughed at $5.5 million in Q2 2023.
  • A 5-year average of $7.2 million and a median of $6.7 million in 2022 define the central range for Non-Current Deffered Revenue.
  • Biggest five-year swings in Non-Current Deffered Revenue: tumbled 31.26% in 2022 and later skyrocketed 78.94% in 2025.
  • Year by year, Non-Current Deffered Revenue stood at $8.6 million in 2021, then crashed by 31.26% to $5.9 million in 2022, then increased by 9.7% to $6.5 million in 2023, then grew by 11.03% to $7.2 million in 2024, then increased by 28.13% to $9.2 million in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for HLTC at $9.2 million in Q4 2025, $10.2 million in Q3 2025, and $9.3 million in Q2 2025.